Abstract
Stroke is a leading cause of serious long-term disability worldwide and the second leading cause of death in many countries. Long-time attempts to salvage dying neurons via various neuroprotective agents have failed in stroke translational research, owing in part to the huge gap between animal stroke models and stroke patients, which also suggests that rodent models have limited predictive value and that alternate large animal models are likely to become important in future translational research. The genetic background, physiological characteristics, behavioral characteristics, and brain structure of large animals, especially nonhuman primates, are analogous to humans, and resemble humans in stroke. Moreover, relatively new regional imaging techniques, measurements of regional cerebral blood flow, and sophisticated physiological monitoring can be more easily performed on the same animal at multiple time points. As a result, we can use large animal stroke models to decrease the gap and promote translation of basic science stroke research. At the same time, we should not neglect the disadvantages of the large animal stroke model such as the significant expense and ethical considerations, which can be overcome by rodent models. Rodents should be selected as stroke models for initial testing and primates or cats are desirable as a second species, which was recommended by the Stroke Therapy Academic Industry Roundtable (STAIR) group in 2009.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655–1711
Amiridze N, Gullapalli R, Hoffman G, Darwish R (2009) Experimental model of brainstem stroke in rabbits via endovascular occlusion of the basilar artery. J Stroke Cerebrovasc Dis 18:281–287
Beuing O, Boese A, Kyriakou Y, Deuerling-Zengh Y, Jollenbeck B, Scherlach C, Lenz A, Serowy S, Gugel S, Rose G, Skalej M (2014) A novel technique for the measurement of CBF and CBV with robot-arm-mounted flat panel CT in a large-animal model. AJNR Am J Neuroradiol 35:1740–1745
Bihel E, Pro-Sistiaga P, Letourneur A, Toutain J, Saulnier R, Insausti R, Bernaudin M, Roussel S, Touzani O (2010) Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging, histological, and immunohistochemical investigations. J Cereb Blood Flow Metab 30:273–285
Boltze J, Forschler A, Nitzsche B, Waldmin D, Hoffmann A, Boltze CM, Dreyer AY, Goldammer A, Reischauer A, Hartig W, Geiger KD, Barthel H, Emmrich F, Gille U (2008) Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J Cereb Blood Flow Metab 28:1951–1964
Cai B, Lin Y, Xue XH, Fang L, Wang N, Wu ZY (2011) TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol 227:224–231
Cook DJ, Teves L, Tymianski M (2012) Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483:213–217
Cook DJ, Tymianski M (2011) Translating promising preclinical neuroprotective therapies to human stroke trials. Expert Rev Cardiovasc Ther 9:433–449
Coon AL, Arias-Mendoza F, Colby GP, Cruz-Lobo J, Mocco J, Mack WJ, Komotar RJ, Brown TR, Connolly ES Jr (2006) Correlation of cerebral metabolites with functional outcome in experimental primate stroke using in vivo 1H-magnetic resonance spectroscopy. AJNR Am J Neuroradiol 27:1053–1058
Dewar D, Yam P, McCulloch J (1999) Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol 375:41–50
Dietz GP (2011) Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: a decade of research. Comment on Cai, et al: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol. 227(1): 224–31. Exp Neurol 231:1–10
Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612–1623
Duong TQ (2013) Magnetic resonance imaging of perfusion-diffusion mismatch in rodent and non-human primate stroke models. Neurol Res 35:465–469
Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, Group S (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40:2244–2250
Fukuda S, del Zoppo GJ (2003) Models of focal cerebral ischemia in the nonhuman primate. ILAR J 44:96–104
Furuichi Y, Maeda M, Matsuoka N, Mutoh S, Yanagihara T (2007) Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator. Exp Neurol 204:138–146
Gladstone DJ, Black SE, Hakim AM, Stroke Foundation Heart of Ontario Centre of Excellence in Stroke R (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123–2136
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, Investigators E (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329
Hanson SR, Harker LA (1987) Baboon models of acute arterial thrombosis. Thromb Haemost 58:801–805
Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, Lum C, Dodd R, Poublanc J, Krings T, Demchuk AM, Goyal M, Anderson R, Bishop J, Garman D, Tymianski M, ENACT trial investigators (2012) Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 11:942–950
Howells DW, Porritt MJ, Rewell SS, O’Collins V, Sena ES, van der Worp HB, Traystman RJ, Macleod MR (2010) Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab 30:1412–1431
Jahan R, Stewart D, Vinters HV, Yong W, Vinuela F, Vandeberg P, Marder VJ (2008) Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysis. Stroke 39:1613–1615
Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, Minematsu K (2001) Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Methods 105:45–53
Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399–415
Mehra M, Henninger N, Hirsch JA, Chueh J, Wakhloo AK, Gounis MJ (2012) Preclinical acute ischemic stroke modeling. J Neurointervent Surg 4:307–313
Mhairi Macrae I (1992) New models of focal cerebral ischaemia. Br J Clin Pharmacol 34:302–308
Moustafa RR, Baron JC (2008) Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol 153(Suppl 1):S44–S54
Nudo RJ, Larson D, Plautz EJ, Friel KM, Barbay S, Frost SB (2003) A squirrel monkey model of poststroke motor recovery. ILAR J 44:161–174
O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59:467–477
Stroke Therapy Academic Industry Roundtable (STAIR) (1999) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30:2752–2758
Traystman RJ (2003) Animal models of focal and global cerebral ischemia. ILAR J 44:85–95
Umemura K, Tsukada H, Kakiuchi T, Yamada N, Matsuura H (2005) PET study of the neuroprotective effect of TRA-418, an antiplatelet agent, in a monkey model of stroke. J Nucl Med 46:1931–1936
Watanabe O, Bremer AM, West CR (1977) Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 1: Angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 8:61–70
Wells AJ, Vink R, Blumbergs PC, Brophy BP, Helps SC, Knox SJ, Turner RJ (2012) A surgical model of permanent and transient middle cerebral artery stroke in the sheep. PLoS One 7, e42157
West GA, Golshani KJ, Doyle KP, Lessov NS, Hobbs TR, Kohama SG, Pike MM, Kroenke CD, Grafe MR, Spector MD, Tobar ET, Simon RP, Stenzel-Poore MP (2009) A new model of cortical stroke in the rhesus macaque. J Cereb Blood Flow Metab 29:1175–1186
Writing Group Members, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2010) Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 121:e46–e215
Acknowledgments
This work was supported by grant No. 81171114 of Natural Science Foundation of China (BC), grant No. 2014-ZQN-ZD-18 of Fujian Provincial Medical Project for Middle-aged and Young Talents (BC), and the National key clinical specialty discipline construction program and the Fujian key clinical specialty discipline construction program.
Conflicts of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cai, B., Wang, N. (2016). Large Animal Stroke Models vs. Rodent Stroke Models, Pros and Cons, and Combination?. In: Applegate, R., Chen, G., Feng, H., Zhang, J. (eds) Brain Edema XVI. Acta Neurochirurgica Supplement, vol 121. Springer, Cham. https://doi.org/10.1007/978-3-319-18497-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-18497-5_13
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18496-8
Online ISBN: 978-3-319-18497-5
eBook Packages: MedicineMedicine (R0)